Thus, our novel derivatives encompassing only seven amino acids are more potent in terms of inhibiting CXCR4-downstream signaling and cancer cell migration than the parental peptide, with no toxic effects shown for the shortest JM#21 derivative in the zebrafish toxicity assay. The gene discussed is CXCR4; the disease is cancer.